Literature DB >> 9303278

Drug-induced hypertension. Recognition and management in older patients.

P W de Leeuw1.   

Abstract

This article reviews the potential of a number of drug classes to produce or aggravate hypertension, with particular emphasis on older patients. Although little information is available regarding the hypertensive effects of mineralocorticoids in the elderly, glucocorticoids usually induce an increase in blood pressure (BP) that is dosage-dependent. Nonsteroidal anti-inflammatory drugs occasionally increase BP, but this effect is not usually clinically relevant. The alleged hypertensive potential of oral antihyperglycaemic agents has not yet been substantiated. In contrast, some antidepressants may be particularly dangerous in terms of their hypertensive complications. Although hypertension may be induced by monoamine oxidase inhibitors (MAOIs) given as monotherapy, severe hypertension is more likely to occur when MAOIs are combined with other sympathomimetic drugs. Several other drugs may also increase the risk of hypertension in elderly patients, but reliable data are lacking for most of these agents. Elderly people who are being treated with drugs that may increase BP should be closely monitored. This is particularly true for drugs that act on the CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303278     DOI: 10.2165/00002512-199711030-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  38 in total

1.  Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.

Authors:  J I Drayer; H J Keim; M A Weber; D B Case; J H Laragh
Journal:  Am J Med       Date:  1976-05-31       Impact factor: 4.965

2.  Studies on the mechanism of mineralocorticoid-induced blood pressure increase in man.

Authors:  A Distler; T Philipp; B Lüth; G Wucherer
Journal:  Clin Sci (Lond)       Date:  1979-12       Impact factor: 6.124

3.  Paradoxical hypertension from clonidine.

Authors:  E Young; B A Levey; A P Shapiro
Journal:  Ann Intern Med       Date:  1984-08       Impact factor: 25.391

4.  Does long-term low-dose corticosteroid therapy cause hypertension?

Authors:  S H Jackson; D G Beevers; K Myers
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

5.  The direct effect of hypoglycaemic sulphonylureas on myocardial contractile force and arterial blood pressure.

Authors:  G Pogátsa; E Dubecz
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

6.  Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.

Authors:  C B Taylor; C Hayward; R King; A Ehlers; J Margraf; R Maddock; D Clark; W T Roth; W S Agras
Journal:  J Clin Psychopharmacol       Date:  1990-04       Impact factor: 3.153

7.  Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.

Authors:  A G Johnson; T V Nguyen; R O Day
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

8.  No adverse effect of non-steroidal anti-inflammatory drugs, sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in elderly hypertensive patients.

Authors:  K Takeuchi; K Abe; M Yasujima; M Sato; M Tanno; K Sato; K Yoshinaga
Journal:  Tohoku J Exp Med       Date:  1991-11       Impact factor: 1.848

9.  A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure.

Authors:  J E Pope; J J Anderson; D T Felson
Journal:  Arch Intern Med       Date:  1993-02-22

10.  Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy.

Authors:  J H Gurwitz; J Avorn; R L Bohn; R J Glynn; M Monane; H Mogun
Journal:  JAMA       Date:  1994-09-14       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.